TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ESP Life Sciences Consulting AB
Closing information (x1000 EUR)
| Closing information | 2024/01 | 2023/01 | 2022/01 |
| Turnover |
84
|
68
|
96 |
| Financial expenses |
5
|
0
|
0 |
| Earnings before taxes |
18
|
26
|
58 |
| EBITDA |
23
|
25
|
59 |
| Total assets |
126
|
122
|
116 |
| Current assets |
121
|
118
|
115 |
| Current liabilities |
79
|
43
|
53 |
| Equity capital |
46
|
77
|
61 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Solvency |
36.5%
|
63.1%
|
52.6% |
| Turnover per employee |
84
|
68
|
96 |
| Profit as a percentage of turnover |
21.4%
|
38.2%
|
60.4% |
| Return on assets (ROA) |
18.3%
|
21.3%
|
50.0% |
| Current ratio |
153.2%
|
274.4%
|
217.0% |
| Return on equity (ROE) |
39.1%
|
33.8%
|
95.1% |
| Change turnover |
15
|
-21
|
25 |
| Change turnover % |
22%
|
-23%
|
36% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.